Effect of Liraglutide on Glycaemic Control in Subjects With Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 10 Mar 2017
At a glance
- Drugs Liraglutide (Primary) ; Glibenclamide
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 03 Mar 2010 Results of the initial 24-week treatment period published in Current Medical Research and Opinion.
- 18 Oct 2009 Results presented at the 20th World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History